MADISON, Wis., May 27, 2022 /PRNewswire/ — Exact Sciences Corp. (Nasdaq: EXAS), a leader in advanced cancer diagnostics, today announced that company management will be participating in the following conferences and invited investors to participate via webcast.
- William Blair 42n/a Annual Growth Equity Conference, Chicago
Presentation on Monday, June 6, 2022 at 3:40 p.m. ET
- Jefferies Healthcare Conference, New York
Fireside Chat on Wednesday, June 8, 2022 at 1 p.m. ET
- Goldman Sachs 43rd Annual World Health Care Conference, Rancho Palos Verdes
Fireside Chat on Monday, June 13, 2022 at 6:20 p.m. ET
- Nephron Liquid Biopsy Innovation Symposium, virtual
Fireside Chat on Tuesday, June 21, 2022 at 11 a.m. ET
The webcasts are available on the Investor Relations section of Exact Sciences’ website at www.exactsciences.com.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions that provide the clarity needed to take life-changing action, sooner. Building on the success of Cologuard® and oncotype® tests, Exact Sciences invests in its product portfolio to support patients before and throughout their cancer diagnosis and treatment. Exact Sciences brings together visionary collaborators to advance the fight against cancer. For more information, visit the company’s website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or search for Exact Sciences on Facebook.
Exact Sciences Corp.
See original content to download multimedia: https://www.prnewswire.com/news-releases/exact-sciences-to-participate-in-june-investor-conferences-301556503.html
SOURCE Exact Sciences Corporation
Company Codes: NASDAQ-SMALL:EXAS